Company Profile

Akoya Biosciences Inc
Profile last edited on: 9/10/2023      CAGE: 7NJQ4      UEI: NHN4QEBQTJT3

Business Identifier: Multi-parameter tissue analysis platform: spatially-resolved, quantitative tissue phenotyping at cellular and subcellular level
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Campus Drive 6th Floor
Marlborough, MA 01752
   (408) 394-9403
Location: Multiple
Congr. District: 03
County: Middlesex

Public Profile

Akoya Biosciences - designated The Spatial Biology Company™ - is structured to offer end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research. These capablites are enabling the development of more precise therapies for immuno-oncology and other drug development applications. Anchored in work undertakan at Stanford by one of the firm's Founders - Dr Gary Nolan - The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX® system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics™ platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials. In late 2018 it was announced that Akoya Biosciences Acquires Phenoptics Portfolio from PerkinElmer. PerkinElmer has grown its Phenoptics business, to be an industry leader in multiplex immunofluorescence. This acquisition establishes Akoya as a leading provider of quantitative tissue biomarker evaluation, from discovery through translational and clinical research.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Brian McKelligon -- Chief Executive Officer

  Chi Buckley -- Senior Sales Executive

  Jack Fuchs -- CFO

  Maria Elena Gallina -- Application Scientist

  Yury Goltsev -- Co-Founder

  Paul Grass -- Vice President of Sales

  Julia Kennedy Darling -- Director of Applications Development

  Joseph Jung-Woong Kim -- R&D Scientist / Systems Engineer

  Won-Mean Lee -- Senior Software Engineer

  Sejal Mistry -- Research Associate

  Nadezhda (Nadya) Nikulina -- Senior Research Associate

  Garry Nolan -- Founder

  Nikolay Samusik -- Founder

  Chris Streck -- Vice President of Marketing

  Ash Wilson -- Director Of Support